Barycki; Rafal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Barycki; Rafal.The latest application filed is for "(22e)-2-methylene-22-dehydro-1alpha,24,25-trihydroxy-19-nor-vitamin d3 analogs".

Company Profile

0.25.19

Barycki; Rafal - Madison WI US
Barycki; Rafal - Warsaw N/A PL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2-methylene-(22E)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs Grant 10,479,764 - DeLuca , et al. Nov	2019-11-19
(22E)-2-methylene-26,27-cyclo-22-dehydro-1.alpha.-hydroxy-19-norvitamin D.sub.3 derivatives Grant 9,834,512 - DeLuca , et al. December 5, 2	2017-12-05
(22E)-2-methylene-22-dehydro-1.alpha.,24,25-trihydroxy-19-nor-vitamin D.sub.3 analogs Grant 9,416,102 - DeLuca , et al. August 16, 2	2016-08-16
(20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D.sub.3 analogs and their uses Grant 9,290,447 - DeLuca , et al. March 22, 2	2016-03-22
(22e)-2-methylene-22-dehydro-1alpha,24,25-trihydroxy-19-nor-vitamin D3 Analogs App 20140206655 - DeLuca; Hector F. ; et al.	2014-07-24
22-haloacetoxy-homopregnacalciferol analogs and their uses Grant 8,754,067 - DeLuca , et al. June 17, 2	2014-06-17
1-desoxy-2-methylene-19-nor-vitamin D analogs and their uses Grant 8,642,579 - DeLuca , et al. February 4, 2	2014-02-04
2-methylene-1.alpha.-hydroxy-18,19,21-trinorvitamin D.sub.3 analogs and uses thereof Grant 8,575,136 - DeLuca , et al. November 5, 2	2013-11-05
2-methylene-19-nor-vitamin D analogs and their uses Grant 8,518,917 - DeLuca , et al. August 27, 2	2013-08-27
Crystallization of 1.alpha.-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol Grant 8,420,839 - DeLuca , et al. April 16, 2	2013-04-16
Crystallization of 1alpha-Hydroxy-2-Methylene-18,19-Dinor-Homopregnacalciferol App 20130090486 - DeLuca; Hector F. ; et al.	2013-04-11
2-Methylene-(22E)-25-Hexanoyl-24-OXO-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs App 20130005686 - DeLuca; Hector F. ; et al.	2013-01-03
(22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin D3 Derivatives App 20120309719 - DeLuca; Hector ; et al.	2012-12-06
(20S)-24-(p-Toluenesulfonyloxy)-25,26,27-Trinorvitamin D3 Analogs and Their Uses App 20120283227 - DeLuca; Hector F. ; et al.	2012-11-08
2-Methylene-19-Nor-Vitamin D Analogs and Their Uses App 20120157418 - DeLuca; Hector F. ; et al.	2012-06-21
22-Haloacetoxy-Homopregnacalciferol Analogs and Their Uses App 20120149669 - DeLuca; Hector F. ; et al.	2012-06-14
1-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses App 20110082121 - DeLuca; Hector F. ; et al.	2011-04-07
Vitamin D receptor antagonists and their use in treating asthma Grant 7,915,242 - DeLuca , et al. March 29, 2	2011-03-29
2-Alkylidene-18,19-Dinor-Vitamin D Compounds App 20100179344 - DeLuca; Hector F. ; et al.	2010-07-15
(20R)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs Grant 7,718,638 - DeLuca , et al. May 18, 2	2010-05-18
(20S)-23,23-difluoro-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs Grant 7,718,637 - DeLuca , et al. May 18, 2	2010-05-18
2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vit- amin D analogs Grant 7,713,953 - DeLuca , et al. May 11, 2	2010-05-11
2-alkylidene-18,19-dinor-vitamin D compounds Grant 7,713,951 - DeLuca , et al. May 11, 2	2010-05-11
2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin D3 and uses thereof Grant 7,704,981 - DeLuca , et al. April 27, 2	2010-04-27
2-methylene-1.alpha.,25-dihydroxy-19,21-dinorvitamin D.sub.3 analogs and uses thereof Grant 7,648,973 - DeLuca , et al. January 19, 2	2010-01-19
2-methylene-1.alpha.-hydroxy-19,21-dinorvitamin D.sub.3 analogs and uses thereof Grant 7,648,972 - DeLuca , et al. January 19, 2	2010-01-19
2-Methylene-(22E)-25-(1-Methylene-Hexyl)-26,27-Cyclo-22-Dehydro-19-Nor-Vit- amin D Analogs App 20100009943 - DeLuca; Hector F. ; et al.	2010-01-14
(20S)-23,23-Difluoro-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs App 20090170818 - DeLuca; Hector F. ; et al.	2009-07-02
(20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs App 20090170819 - DeLuca; Hector F. ; et al.	2009-07-02
2-Methylene-1Alpha-Hydroxy-19,21-Dinorvitamin D3 Analogs and Uses Thereof App 20070238702 - DeLuca; Hector F. ; et al.	2007-10-11
2-Methylene-1Alpha,25-Dihydroxy-18,19,21-Trinorvitamin D3 and Uses Thereof App 20070238705 - DeLuca; Hector F. ; et al.	2007-10-11
2-Methylene-1alpha-Hydroxy-18,19,21-Trinorvitamin D3 Analogs and Uses Thereof App 20070238701 - DeLuca; Hector F. ; et al.	2007-10-11
2-Methylene-1Alpha,25-Dihydroxy-19,21-Dinorvitamin D3 Analogs and Uses Thereof App 20070238706 - DeLuca; Hector F. ; et al.	2007-10-11
2-Methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol and its uses Grant 7,238,681 - DeLuca , et al. July 3, 2	2007-07-03
2-Methylene-18,19-dinor-1alpha-hydroxy-homopregnacalciferol and its uses App 20060122157 - DeLuca; Hector F. ; et al.	2006-06-08
2-alkylidene-18,19-dinor-vitamin D compounds App 20050227950 - DeLuca, Hector F. ; et al.	2005-10-13
Vitamin D receptor antagonists and their use in treating asthma App 20050182033 - DeLuca, Hector F. ; et al.	2005-08-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.